Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Partial-onset Seizures”

193 trials

Showing 20 of 193 results

Large-scale testing (Phase 3)Study completedNCT00700310
What this trial is testing

Evaluating Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures

Who this might be right for
Refractory Partial Seizures
Eisai Inc. 712
Large-scale testing (Phase 3)Study completedNCT00566254
What this trial is testing

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

Who this might be right for
Epilepsy; Paediatric Partial Onset Seizures
Eisai Inc. 207
Large-scale testing (Phase 3)Active Not RecruitingNCT05067634
What this trial is testing

Safety and Efficacy Study of Cenobamate in Pediatric Subjects 2-17 Years of Age With Partial-onset (Focal) Seizures

Who this might be right for
Partial Epilepsy
SK Life Science, Inc. 140
Large-scale testing (Phase 3)Looking for participantsNCT06132893
What this trial is testing

Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy

Who this might be right for
Focal Epilepsy
Biohaven Therapeutics Ltd. 390
Early research (Phase 1)Study completedNCT00233012
What this trial is testing

The Pharmacokinetics, Safety and Tolerability of Topiramate in Infants (Age 1-24 Months) With Refractory Partial-onset Seizures

Who this might be right for
Seizures
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 16
Large-scale testing (Phase 3)Study completedNCT00150800
What this trial is testing

This Trial, Evaluating the Long-term Safety and Tolerability of Brivaracetam Will Provide Subjects Suffering From Epilepsy, Who May Have Benefited From Brivaracetam as Adjunctive Treatment, the Opportunity to Receive Open Label Brivaracetam Treatment

Who this might be right for
Epilepsy
UCB PHARMA Inc. (US) 668
Large-scale testing (Phase 3)Study completedNCT02124564
What this trial is testing

A Trial to Evaluate the Long Term Safety and Tolerability of Lacosamide Taken as Monotherapy in Adults With Partial-onset Seizures

Who this might be right for
EpilepsyPartial-onset Seizures
UCB Japan Co. Ltd. 19
Large-scale testing (Phase 3)Study completedNCT00160628
What this trial is testing

Open Label Safety and Efficacy Study of Levetiracetam in Korean Patients With Epilepsy

Who this might be right for
Epilepsy, Partial
UCB Pharma 100
Large-scale testing (Phase 3)Ended earlyNCT01668654
What this trial is testing

Long-term, Open-label Safety Extension Study of Retigabine/Ezogabine in Pediatric Subjects (>= 12 Years Old) With POS or LGS

Who this might be right for
Epilepsy
GlaxoSmithKline 4
Large-scale testing (Phase 3)WithdrawnNCT00175864
What this trial is testing

Open Label Study (Everyone Who Participates Receives Drug) to Further Determine How Safe and Effective Oral Treatment of Seletracetam is in Patients With Refractory Epilepsy.

Who this might be right for
Epilepsy
UCB Pharma
Large-scale testing (Phase 3)Ended earlyNCT00699283
What this trial is testing

A Double-blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (≥ 16 to 75 Years Old) With Partial Onset Seizures

Who this might be right for
Epilepsy
UCB Pharma 62
Large-scale testing (Phase 3)Study completedNCT02072824
What this trial is testing

A Safety, Efficacy, and Tolerability Trial of Pregabalin as Add-On Treatment in Pediatric Subjects <4 Years of Age With Partial Onset Seizures.

Who this might be right for
Partial Onset Seizures
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 175
Large-scale testing (Phase 3)Ended earlyNCT00698581
What this trial is testing

A Double-blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (≥ 16 to 75 Years Old) With Partial Onset Seizures

Who this might be right for
Epilepsy
UCB Pharma 88
Testing effectiveness (Phase 2)Looking for participantsNCT06590896
What this trial is testing

Safety of Cenobamate in Japanese Subjects With Partial Onset Seizures

Who this might be right for
Epilepsies, Partial
Ono Pharmaceutical Co., Ltd. 100
Large-scale testing (Phase 3)Study completedNCT00699972
What this trial is testing

Evaluating the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures

Who this might be right for
Refractory Partial Seizures
Eisai Inc. 390
Large-scale testing (Phase 3)Study completedNCT01339559
What this trial is testing

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Epilepsy

Who this might be right for
Epilepsy
UCB BIOSCIENCES, Inc. 767
Testing effectiveness (Phase 2)Study completedNCT00152503
What this trial is testing

Study With Subjects 18-65 Years Old With Partial Onset Seizures Who Are Currently Taking Levetiracetam

Who this might be right for
Epilepsy, Partial
UCB Pharma SA 59
Not applicableLooking for participantsNCT06657378
What this trial is testing

Evaluate the Safety of Fycompa Injection in Participants With Partial-Onset Seizures or Primary Generalized Tonic- Clonic Seizures

Who this might be right for
Partial-Onset SeizuresPrimary Generalized Tonic-clonic Seizures
Eisai Co., Ltd. 110
Large-scale testing (Phase 3)Study completedNCT00266591
What this trial is testing

The Efficacy and Safety of Topiramate Treatment in Patients With Epilepsy

Who this might be right for
EpilepsySeizures
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 51
Large-scale testing (Phase 3)Study completedNCT00615615
What this trial is testing

Efficacy and Tolerability of Levetiracetam Add-On Treatment in Refractory Pediatric Patients With Partial Onset Seizures

Who this might be right for
Epilepsy
UCB Pharma 216
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation